Search results
Results from the WOW.Com Content Network
Dietary supplements, self-medication, [248] and specialized diets are sometimes used by people with ADHD with the intent to mitigate some or all of the symptoms. However a 2009 article in the Harvard Mental Health Letter states, "Although vitamin or mineral supplements [micronutrients] may help children diagnosed with particular deficiencies ...
There is a risk of dangerously low blood pressure if people take mianserin along with diazoxide, hydralazine, or nitroprusside. Mianserin can make antihistamines and antimuscarinics have stronger effects. Mianserin should not be taken with apraclonidine, brimonidine, sibutramine, or the combination drug of artemether with lumefantrine. [6]
Iron supplements, also known as iron salts and iron pills, are a number of iron formulations used to treat and prevent iron deficiency including iron deficiency anemia. [ 11 ] [ 12 ] For prevention they are only recommended in those with poor absorption , heavy menstrual periods , pregnancy , hemodialysis , or a diet low in iron.
A motivation-enhancing drug, [2] [3] also known as a pro-motivational drug, [1] is a drug which increases motivation. [ 4 ] [ 1 ] Drugs enhancing motivation can be used in the treatment of motivational deficits , for instance in depression , schizophrenia , and attention deficit hyperactivity disorder (ADHD).
Guanfacine, sold under the brand name Tenex (immediate-release) and Intuniv (extended-release) among others, is an oral alpha-2a agonist medication used to treat attention deficit hyperactivity disorder (ADHD) and high blood pressure. [3] [10] Common side effects include sleepiness, constipation, and dry mouth. [10]
For premium support please call: 800-290-4726 more ways to reach us
Iron supplement medication interactions. Over-the-counter medications like antacids (calcium-containing) and acid suppressors like PPIs and histamine blockers can also decrease absorption ...
This is a list of investigational attention deficit hyperactivity disorder drugs, or drugs that are currently under development for clinical use in the treatment of attention deficit hyperactivity disorder (ADHD) but are not yet approved. Chemical/generic names are listed first, with developmental code names, synonyms, and brand names in ...